STAT 调查:医生对 Watchman 心脏植入器存疑,Boston Scientific 以销售话术回应
STAT+: Doctors have questions about the Watchman. Boston Scientific has a sales pitch.
STAT 与 Boston Globe 的调查报道称,Watchman 心脏植入器已在全球植入超过 80 万例,但医生对该器械仍有疑问,Boston Scientific 则以销售推介回应。报道提到,Boston Scientific 十多年前投入数亿美元收购这款小型心脏植入器,随后经历 FDA 长达数年的审批争论,最终获批时仅限一小部分患者使用。该报道为 STAT+ 付费内容,正文未完整公开。
So far, doctors have implanted more than 800,000 devices in patients around the world.
By Elizabeth Koh and Liz Kowalczyk — Boston Globe
Nov. 13, 2026
Despite all the setbacks, Boston Scientific won’t stop pushing the Watchman.
The medical-device giant committed hundreds of millions to acquire the tiny heart implant more than a decade ago, and then endured a years-long debate at the Food and Drug Administration over whether to approve it.
When that approval finally came through, for a limited pool of patients, Boston Scientific was prepared with a plan for something much larger.
STAT+ Exclusive Story
Already have an account? Log in

This article is exclusive to STAT+ subscribers
Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.
Already have an account? Log in
To read the rest of this story subscribe to STAT+.
-
Elizabeth Koh and Liz Kowalczyk — Boston Globe
来源:STAT News · statnews.com